# hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases

> **NCT06607900** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 120 (estimated)

## Conditions studied

- Alzheimer Disease
- Parkinson Disease
- Lewy Body Dementia
- Multiple System Atrophy
- Fronto-temporal Dementia
- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** hUC-MSC-sEV-001 nasal drops

## Key facts

- **NCT ID:** NCT06607900
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2027-08-31
- **Final completion:** 2028-08-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06607900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06607900, "hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06607900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*